Age (median, years) | 44 (28–79) | 47 (27–79) | 44 (31–66) | 0.897 |
Squamous-cell carcinoma (%) | 16 (66.7) | 45 (69.2) | 11 (61.1) | 0.814 |
Satge of disease IB1(%) | 23 (95.8) | 59 (90.8) | 15 (83.3) | 0.228 |
Lymphovascular space infiltration (%) | 7/23 (30.4) | 22/62 (35.5) | 9/17 (52.9) | 0.166 |
Tumoral Grade 3 (%) | 5/12 (41.7) | 15/57 (26.3) | 2/8 (25) | 0.283 |
ECOG performance-status 0 score | 18/19 (94.7) | 61/61 (100) | 1/12 (83.3) | 0.503 |
Adjuvant treatment- None (%) | 14/20 (70) | 36/65 (55.4) | 6/14 (42.9) | 0.219 |
Chemotherapy + Radiotherapy | 4/20 (20) | 15/65 (23.1) | 5/14 (35.7) | |
Radiotherapy | 2/20 (10) | 14/65 (21.6) | 3 (21.3) | |